Review article: impact of night‐time reflux on lifestyle − unrecognized issues in reflux disease
Open Access
- 4 November 2004
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 20 (s9) , 3-13
- https://doi.org/10.1111/j.1365-2036.2004.02237.x
Abstract
Gastro‐oesophageal reflux disease (GERD), manifesting with symptoms including heartburn and regurgitation, affects people during both daytime and nocturnal hours. Night‐time GERD has been reported to have a greater impact on a patient's life than daytime GERD due to prolonged oesophageal acid exposure time per reflux episode. To further understand this issue, it is important to implement quality of life (QOL) measures. QOL studies are becoming increasingly important to physicians in making clinical decisions, and generic and disease‐specific health‐related QOL (HRQL) tools have been developed to measure a wide variety of topics. There are currently no universally accepted guidelines on how to best measure HRQL in GERD patients. It is important to note that these surveys may not yield accurate results because many GERD sufferers may feel that their symptoms are not serious enough to seek treatment. Some surveys include the GERD‐HRQL assessment, the Short Form Health Survey (SF‐36), and the Gallup survey. When compared with daytime GERD patients, night‐time GERD patients may suffer from sleep deprivation, which in turn leads to physical and emotional problems and a poor overall QOL. Studies indicate that the prevalence and impact of night‐time heartburn have been underestimated and that adequate treatment of symptoms is often not achieved. In addition, GERD greatly affects work productivity and leads to a significant economic burden on society. Although limited studies are available on the impact of pharmacological treatment on GERD QOL, recent findings indicate that proton pump inhibitors are more effective than H2‐receptor antagonists for the improvement of overall QOL.Keywords
This publication has 33 references indexed in Scilit:
- Quality of life in relation to symptoms in patients with gastro‐oesophageal reflux disease — an analysis based on the ProGERD initiativeAlimentary Pharmacology & Therapeutics, 2003
- The impact of gastroesophageal reflux disease on quality of lifeSurgical Endoscopy, 2003
- The Impact of Treatment for Gastro-Oesophageal Reflux Disease on Health-Related Quality of LifePharmacoEconomics, 2003
- Complete resolution of heartburn symptoms and health‐related quality of life in patients with gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1999
- The Impact of Gastroesophageal Reflux Disease on Health-related Quality of Life 11Supported by research funding from Astra/Merck, Wayne, Pennsylvania.The American Journal of Medicine, 1998
- Health-Related Quality of Life Outcomes of Omeprazole versus Ranitidine in Poorly Responsive Symptomatic Gastroesophageal Reflux DiseaseDigestive Diseases, 1998
- Measuring Health-Related Quality of Life in Patients with Upper Gastrointestinal DiseaseDigestive Diseases, 1998
- Daytime sleepiness, snoring and gastro‐oesophageal reflux amongst young adults in three European countriesJournal of Internal Medicine, 1995
- Long-Term Aims of Treatment of Reflux Disease, and the Role of Non-Drug MeasuresDigestion, 1992
- Symptomatic gastroesophageal reflux: Incidence and precipitating factorsDigestive Diseases and Sciences, 1976